Lisa Nibauer joined OraSure Technologies (NASDAQ: OSUR) as Executive Vice President Business Unit Leader, Diagnostics in May 2020. OraSure develops and delivers game-changing, innovative sampling tools, services and diagnostics designed to help its customers and partners get the best answers to their most critical questions, more easily and with more illuminating insights. OraSure is leveraging its global leadership in infectious disease diagnostics to develop tests for COVID-19. 

Prior to joining OraSure, Ms. Nibauer spent eight years at BD Becton Dickinson, Inc. (“BD”), most recently as VP/GM, Global Medication Delivery Solutions. In that role, she had general management responsibility for $1.6 billion in annual revenue and a team of over 300 people globally and was also accountable for the Global Marketing function for the largest business unit in BD. Prior to that, also at BD, Ms. Nibauer held the positions of VP/GM, Global PreAnalytical Systems Business & Global Marketing and Senior Director, Global Blood Collection Acquisition Platform. Prior to joining BD, she held general management, sales and marketing positions with increasing responsibilities at Adlens Beacon Inc., Schering-Plough Consumer Healthcare (Bayer), General Mills, Elf Atochem, and ICI (now part of AstraZeneca, Henkel and AkzoNobel). Ms. Nibauer earned an M.B.A. from UCLA Anderson School of Management and a B.S. in Chemical Engineering from Lehigh University. 

“A career in STEM ignites the heart and mind, as you will work on overcoming some of the world’s biggest challenges and really making a difference.”